Category Archives: Penny Stocks

[ May 5, 2016 | Author: admin | Views: 79231 | Weather: | Mood: normal]

Deutsche Bank’s Gregg Gilbert argues that shares of Endo International (ENDP) are “undervalued” despite “concerns aplenty.” He explains why: Endo shares have been under significant pressure this year for a variety of reasons, including but not necessarily limited to soft generic trends in 4Q15/1Q16, earlier-than-expected generic competition to Voltaren Gel, product liability (mesh) concerns, opioid demand concerns, and the debt load, all in the context of an unpopular sector. While we are not dismissive of these issues, it does feel like the stocks sell-off has been much more extreme than fundamentals would support, perhaps suggesting non-fundamental or forced selling (~35% of the float traded in the past two weeks). We see Endos Q1 call in early May as an important milestone in that new money may prefer to see Q1 trends and updated 16 guidance. Our below-consensus revenue and EPS estimates for 16 ($4.1bn and $5.34 vs. consensus of $4.3bn … Continue reading

[ April 30, 2016 | Author: admin | Views: 64381 | Weather: | Mood: normal]

Can I take a tax deduction for my long-term-care insurance premiums? Take Our Quiz: Is It Tax Deductible? Maybe. If you have a tax-qualified long-term-care insurance policy, you may be able to deduct a portion of your premiums as a medical expense. (Most traditional long-term-care policies qualify, but ask your insurer.) You can deduct eligible out-of-pocket medical expenses only if you itemize your deductions, and then only the portion of medical expenses that is more than 10% of your adjusted gross income (7.5% if you are 65 or older). For example, if you’re 50 years old and your adjusted gross income is $50,000, you can deduct eligible out-of-pocket medical expenses above $5,000. The amount that counts toward the deduction for long-term-care policies is based on your age. If you’re 40 or younger, you can count up to $380 you paid in qualified long-term-care premiums in 2015. You can count up … Continue reading

[ April 29, 2016 | Author: admin | Views: 96875 | Weather: | Mood: normal]

The crowd piled into investment-grade bonds last week as economic worries triggered an exodus out of risky assets. Reviewing the major asset classes for the week just passed through an ETF lens reveals sharply divided results. The safe-haven trade generated handsome gains for several ETFs representing broad measures of the global fixed-income realm for the five trading days through Feb. 5. Even the usually weak corner of emerging-market government bonds caught a break. Stocks, REITs, and commodities, by contrast, suffered hefty losses. Last week’s big winner: SPDR International Treasury Bond (BWX), which posted a strong 2.6% total return. At the opposite end of last week’s performance ledger: US equities, based on Vanguard Total Stock Market (VTI), which tumbled 3.1%. Hot Managed Healthcare Stocks To Buy For 2016: URS Corporation(URS) URS Corporation provides engineering, construction, and technical services to the power, infrastructure, federal, and industrial and commercial market sectors in the … Continue reading

[ April 29, 2016 | Author: admin | Views: 34172 | Weather: | Mood: normal]

As depressed oil prices persist, some of the world’s top oil-producing countries will meet in Doha, Qatar, this weekend. The 13 OPEC members, Russia, Mexico and another five non-OPEC nations will get together to discuss possible strategies, including a production freeze at January levels, to drive oil prices up. On Friday morning, Phil Davis, founder of Phil's Stock World, was on Benzinga’s Pre-Market Prep show, and discussed a few implications of, and ways to play, the Doha meeting. The Meeting And Circumstances The meeting “will not have the impact people think it’s going to have,” he assured. “OPEC is getting together with Russia [and] that’s a big deal, that’s never happened before.” And, what they will try to do is agree on a production freeze, Davis went on to explain. Hot High Tech Stocks To Watch Right Now: Dover Corporation(DOV)   Dover Corporation manufactures and sells a range of equipment … Continue reading

[ April 28, 2016 | Author: admin | Views: 73135 | Weather: | Mood: normal]

Citigroup’s Robyn Karnauskas and Mohit Bansal have the details on Gilead Sciences’ (GILD) latest hepatitis-C drug sales: Gilead Sciences’ Sovaldi IMS released data for the week ending 4/1/2016 this AM. Gilead HCV is at 92% share… Gilead HCV: franchise was up (3.0%) w/w in terms of new starts and is at 92% share among the new patients. We are in week #9 of new competition launch. New pt. starts are tracking 0.9% above last Q. However, total scripts are tracking ~6% below last Q and pointing to 1Q16 sales at $2.22B vs. $2.46B consensus. VA sales are a big unknown as lack of budget impacted Q415 sales. We do not think IMS fully captures VA sales and their annual budget of $1.5B (for HCV) could be the differentiating factor. In Q415, IMS projected volume decline of 10% but actual decline was 27% due to lower VA sales. Top 10 Diversified … Continue reading